First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis

I.v.(intravenous) dose-escalation. Highest dose planned for i.v. administration is 10 mg/kg

Administered i.v.(intravenous) or s.c. (subcutaneous, under the skin).

The s.c. (subcutaneous, under the skin) part will not start until at least two i.v. dose levels have been evaluated for safety and pharmacokinetics. Highest dose planned for s.c. administration is 4 mg/kg